Analyst Expect Big Moves From Apogee Therapeutics Inc. (NASDAQ: APGE)
Currently, there are 37.17M common shares owned by the public and among those 37.12M shares have been available to trade. The company’s stock has a 5-day price change of 5.81% and 12.12% over the past three months. APGE shares are trading 83.14% year to date (YTD), with the 12-month market performance up to 114.10% higher. […]
